02.09.2015 Views

Gesellschaft für Pädiatrische Pneumologie

zum pdf.... - GPP

zum pdf.... - GPP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Weiterbildung<br />

Aus den AGs<br />

den muss. Daneben sind Beispiele<br />

gegeben, wie die Dokumentation<br />

der Weiterbildung erfolgen<br />

kann (Portfolio, Falldiskussion<br />

etc.). Mit diesen praktischen<br />

Empfehlungen geht das<br />

europäische Curriculum über<br />

das hinaus, was derzeit in der<br />

deutschen Weiterbildungsordnung<br />

hinterlegt ist.<br />

Auch wenn die europäischen<br />

Weiterbildungsinhalte formell<br />

<strong>für</strong> die Weiterbildung in<br />

Deutschland nicht verpflichtend<br />

sind, lohnt es sich <strong>für</strong> alle Weiterbilder<br />

und Weiterzubildenden,<br />

einen Blick in diese ausführlichen<br />

europäischen Empfehlungen<br />

zu werfen.<br />

Europäische Prüfung<br />

Im Rahmen der ERS-Jahrestagung<br />

2011 in Amsterdam wird<br />

die erste europäische Prüfung<br />

in Paediatric Respiratory Medicine<br />

stattfinden. Analog zu<br />

den von den Erwachsenen bereits<br />

seit mehreren Jahren angebotenen<br />

Examen wird derzeit<br />

ein Multiple-Choice-Examen<br />

vorbereitet, das <strong>für</strong> auf<br />

natio naler Ebene bereits qualifizierte<br />

Pneumologen den Erwerb<br />

eines European Diploma<br />

ermöglicht. Alle pädiatrischen<br />

Pneumologen in der GPP sind<br />

herzlich eingeladen, an dieser<br />

MCQ-Prüfung teilzunehmen!<br />

Prof. Dr. med. Monika Gappa,<br />

Marien-Hospital Wesel,<br />

Klinik <strong>für</strong> Kinder- und<br />

Jugendmedizin<br />

Pastor-Janßen-Str. 8–38<br />

46483 Wesel<br />

E-Mail: monika.gappa@<br />

marien-hospital-wesel.de,<br />

monika.gappa@prohomine.de<br />

Literaturliste:<br />

[1] Gappa M, Noel JL, Severin T et al.:<br />

Paediatrc HERMES: European Curriculum<br />

Recommendations for Training in Paediatric<br />

Respiratory Medicine. Breathe 2010:<br />

7: 72–79.<br />

[2] Gappa M, Paton J, Baraldi E, Bush<br />

A, Carlsen KH, de Jongste JC, Eber E,<br />

Fauroux B, McKenzie S, Noël JL, Palange<br />

P, Pohunek P, Priftis K, Séverin T, Wildhaber<br />

JH, Zivkovic Z, Zach M: Paediatric<br />

HERMES: update of the European Training<br />

Syllabus for Paediatric Respiratory Medicine.<br />

Eur Respir J 2009 Mar; 33 (3): 464–5.<br />

[3] Gappa M; Paediatric HERMES ERS<br />

Task Force: Paediatric respiratory medicine<br />

the European perspective. Paediatr Respir<br />

Rev 2010 Mar; 11 (1): 64–5<br />

[4] Gappa M, Ferkol T, Kovesi T, Landau L,<br />

McColley S, Sanchez I, Tal A, Wong GW,<br />

Zar H: Pediatric respiratory medicine – an<br />

international perspective. Pediatr Pulmonol<br />

2010 Jan; 45 (1): 14–24. Review. PubMed<br />

PMID: 20014351.<br />

[5] Gappa M, Noël JL, Séverin T, Paton JY;<br />

Paediatric HERMES Task Force: European<br />

Curriculum Recommendations for Training<br />

in Paediatric Respiratory Medicine: one<br />

step further. Eur Respir J 2010 Sep; 36<br />

(3): 478–9.<br />

Syllabus items Knowledge Skills<br />

Attitudes and<br />

behaviour<br />

Level of<br />

competence<br />

Minimum<br />

clinical exposure<br />

Assessment<br />

tools *<br />

Sample clinical<br />

situation<br />

5) Diagnosis and<br />

management of<br />

extrapulmonary<br />

manifestations<br />

of CF<br />

• Range of presentations<br />

of CF<br />

• Presentation of extrapulmonary<br />

manifestations of CF<br />

• Interactions between pulmonary<br />

and nonpulmonary<br />

disease manifestations<br />

• Identification of extrapulmonary<br />

disease<br />

• Ability to judge when to<br />

investigate for subclinical<br />

disease<br />

• Willingness to adopt<br />

holistic approach to clinical<br />

care<br />

3 • Supervision of inpatient<br />

and outpatient management<br />

for at least 1 yr in a<br />

CF centre<br />

• Participation in > 10<br />

MDT discussions<br />

• Portfolio<br />

• Feedback<br />

on letters<br />

• Management of<br />

extrapulmonary<br />

complication of CF,<br />

e.g. diagnosing and<br />

managing CF related<br />

diabetes<br />

6) Evidence-based<br />

management<br />

7) Crossinfection<br />

and hygiene<br />

• Up-to-date knowledge of<br />

published guidelines and<br />

evidence on the management<br />

of CF<br />

• Crossinfection in respiratory<br />

aspects of CF<br />

• Interpretation and application<br />

of guidelines<br />

• Development and implementation<br />

of local infection<br />

control guide lines<br />

• Willingness to formulate<br />

an individualised treatment<br />

plan integrating<br />

evidence-based treatment<br />

and family input<br />

• Willingness to understand<br />

the barriers<br />

to ensuring effective<br />

implementation of crossinfection<br />

prevent ion<br />

policies<br />

3 • Audit of guideline<br />

implementation (at least<br />

one during the time in the<br />

CF unit)<br />

• Portfolio<br />

• Feedback<br />

on letters<br />

• Audit<br />

3 • Audit of hygiene • Audit<br />

• Review of local<br />

pratice<br />

8) Understanding<br />

of microbiology<br />

relevant to CF<br />

• Relevant respiratory pathogens<br />

• Effective respiratory<br />

specimen collection from<br />

children of all ages<br />

3 • Microbiological case<br />

review<br />

• Minimum of five<br />

successful sample<br />

collect ions<br />

• Portfolio<br />

• Managing the first<br />

isolate of pseudomonas<br />

in a child<br />

with CF<br />

9) Knowledge of<br />

emerging treatment<br />

strategies<br />

10) Management<br />

of end-stage<br />

lung disease and<br />

indications for lung<br />

transplantation<br />

• Up-to-date knowledge<br />

of novel and experimental<br />

treatment of CF<br />

• Principles of terminal care<br />

for CF patients<br />

• Indications for referral for<br />

transplant, complications<br />

and outcomes of transplant<br />

• Ability to judge how<br />

and when to adopt novel<br />

treatments into local<br />

practice<br />

• Counselling for transplant<br />

• Management of endstage<br />

respiratory failure<br />

in a CF patient<br />

• Willingness to respond<br />

in an informed and<br />

empathic manner to families'<br />

requests for novel<br />

treatments<br />

• Willingness to understand<br />

the need for<br />

obtaining consent when<br />

initiating novel treatments<br />

• Willingness to demonstrate<br />

effective support for<br />

families and caregivers of<br />

dying patients<br />

• Willingness to acknowledge<br />

the wishes of<br />

patient and family<br />

3 • Discussion of local<br />

applicability and costeffectiveness<br />

of novel<br />

treatments<br />

• Portfolio<br />

3 • Observing and participating<br />

in care of dying<br />

child, learning from experienced<br />

team members<br />

• Portfolio<br />

• Feedback<br />

on letters<br />

• CbD<br />

• Managing a child<br />

with advanced CF<br />

* all items can be assessed using MCQ in a written knowledge-based examination; refer to assessment toolbox for suggested methods<br />

49

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!